Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
PharmaLex Delivering Success with Confidence Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | N/A | |
AventaMed Advancing ENT Surgery AventaMed is an emerging medical device company focused on simplifying surgical procedures and reducing costs for healthcare providers. AventaMed has developed a novel medical device which allows grommets to be placed safely and quickly in an office setting, eliminating the need for general anaesthetic and costly OR time. 7% of all children have grommets (2 million / year), making it a large market, worth over $5.4 billion worldwide. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 9 | |
Perfect Day Complete whey protein, made more sustainably. We’re rethinking everything. Starting with food. Using safe, proven fermentation methods we make animal-free whey protein from microflora – not cows – to make dairy that’s identical to traditional milk. The production of our whey protein emits up to 97% less greenhouse gas emissions, uses up to 99% less blue water, and uses up to 60% less nonrenewable energy, compared to the production of protein found in traditional milk. Our protein comes in a variety of applications including cream cheese, barista milk, ice cream, protein powder, egg replacer, bakery mix, confectionery, and gelato. Some … Type: Startup Activities: agritech biotech deeptech foodtech Technologies: Synthetic Biology | 25 | 5 | 21 | 302 | |
Artus Therapeutics Sealing The Broken Barrier Currently we are not hiring. Please beware of scammers Artus is a pre-clinical stage company developing first-in-class therapeutics for inflammatory and metabolic diseases by targeting barrier dysfunction. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 3 | |
Provention Bio, a Sanofi Company Provention Bio is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated diseases. At Provention Bio, we approach autoimmune disease differently than traditional pharma, with a clear focus on early interception. Before symptoms present, before irreversible damage is done to the bodies, minds, and lives of patients and families, and before it’s too late —this is where we operate. Our lead investigational product candidate is currently under review by the U.S. Food and Drug Administration (FDA) for the delay or prevention of clinical type 1 diabetes in at-risk individuals. … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 1 | 76 | |
GENZ Biotechnology Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
Shift Labs Enabling Safe and Accurate Infusion Therapy for Anyone, Anywhere Shift Labs is a company dedicated to providing safe, accurate and affordable infusion care to everyone, whether they are receiving care in the home, in an outpatient infusion center, or in an emerging market. Our DripAssist Infusion Monitoring platform is an award-winning solution to monitor gravity IV infusions safely and accurately in any environment. By improving the accuracy of gravity infusions and reducing the side effects caused by common errors in infusion rates and volumes, patients are happier and healthier and nurses are in more control. Our solutions ensures all people … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 2 | 2 | 4 | |
Oxurion NV Advancing Science. Enhancing Vision Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to … Type: Startup Activities: biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 34 | |
Alvotech Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 878 | |
Econea [Automatic translation follows] Ecological e-shop with thousands of products that have been typed in detail. We decipher the composition, test it on ourselves, pack with zero waste. Econea - tapped into detail We have been caring for the planet and our customers for over 10 years. We have thousands of products from natural drug stores, cosmetics and healthy snacks lined up on virtual shelves, which we try on our own skin, hair, nose and taste buds. We understand the composition down to the last letter, we pack with maximum zero waste, and yet: ... we don't sew curtains from potato … Type: Startup Activities: retail Technologies: Synthetic Biology | 0 | 0 | 0 | 22 | |
Nanovation Partners, LLC Starting in the mid 1990’s, the founders of Nanovation Partners LLC sponsored research at the University of California at San Diego (UCSD) in the lab of Sungho Jin, PhD. This research showed enhanced osseointegration and reduced implant surface infection by forming thousands of rows of tiny metal oxide nanotubes per square millimeter on the medical implant-to-tissue surface. These nanotubes were formed into the metal oxide surface already present on metal implants. No new materials were formed and no synthetic hydroxyapatite or other coating was needed. The group noticed that nearby stem cells treated the nanotube surfaces more like the outer … Type: Startup Activities: biotech deeptech manufacturing Technologies: New Materials Synthetic Biology | 0 | 0 | 0 | 2 | |
EUROPE TECHNOLOGIES Services and Innovations for your Industrial Processes With more than 25 years of experience, Europe Technologies group offers you its expertise for : • #Industrialization and manufacturing of composite and metallic parts • Design and #manufacturing of robot cells and machines around our processes (metal surface treatment, composite welding, cutting, sanding, acoustic drilling...) • International #MRO services (airplanes, vessels, ...) We support our customers from R&D to industrialization of parts and processes. We are serving all industries where innovations and reliables processes are needed : Aeronautics, Naval, Defense, Energy, Automotive & Transportation, Medical & Cosmetics, Food-Industry... Subsidiaries part of Europe … Type: SMB Activities: industry 4.0 Technologies: Robotics Synthetic Biology | 21 | 9 | 9 | 109 | |
ALSACHIM SAS Your strategic supplier for stable isotope-labeled internal standards Created in 2005, Alsachim is one of the world leaders in the synthesis of stable labeled (13C, 2H, 15N, 34S, 18O) internal standards, used in bioanalysis studies, chemicals, building blocks and metabolites. Based on its expertise, Alsachim develops also Therapeutic Drug Monitoring devices to support hospitals and bioanalyse center to their daily work and routine operation. We supply our products to customers all over the world, spread across the chemical discipline including the pharmaceutical and biotech industry, clinical and bio-analytical CROs, and research institutions, in areas such as Health, Food and Environment. … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 2 | 2 | 0 | 48 | |
AFFICHEM [Automatic translation follows] Affichem is a medicinal chemistry company which develops innovative therapeutic molecules against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 1 | |
HAcare - Medical Furniture French designer and manufacturer of medical devices since 1955 Allibert Medical, Corona Medical and Sotec Medical unite to form the HAcare group. By relying on the know-how of our brands, and the expertise of our teams, we can support you in the choice and installation of medical equipment (medical bed, ambulatory chair, stretcher, etc.), the management of the medication circuit (trolley, cupboard, etc.), home support and fitting out of common living areas (bedside table, dining table, bridge, etc.). lit médicalisé, mobilier modulaire, maintien à domicile, fauteuil ambulatoire, projet global, and accompagnement Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 1 | 78 | |
Rethink Medical SL. Rethink Medical S.L. is a start-up company dedicated to the development of new medical devices in the nursing field. Rethink Medical is a Spanish startup company focused on developing innovative medical devices, mainly in the nursing field, based on real life experiences regarding both patient needs and common hospital procedures. Our first patented product is a urinary catheter We are working on other continence-related projects as well, improving healthcare processes and patient comfort due to the aging of the population and the increased need for these products. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
Probably Genetic Helping people with rare genetic diseases get answers. Probably Genetic helps undiagnosed rare disease patients find answers to their symptoms in a matter of weeks. There are over 400 million people worldwide that have a rare disease — more than cancer and HIV patients combined. Half of those patients are currently undiagnosed and half of them are children, and it takes 5-7 years on average for these patients to get a diagnosis. With our system, patients can get answers in a matter of weeks. Our online Symptom Checker identifies rare disease patients using state-of-the-art machine learning models, gets them tested … Type: Startup Activities: insurtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 31 | |
Laminar Pharma Biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs. Laminar Pharma is a pioneering biopharmaceutical company that focuses on the discovery, rational design and development of a new generation of medicines that act through the innovative therapeutic strategy known as “Membrane-Lipid Therapy” (MLT). Laminar Pharma arose in 2006 as an academic spin-off to commercially develop new scientific know-how and applications generated by leading scientists at the University of the Balearic Islands (UIB) in Mallorca, Spain, headed by Prof. Pablo V. Escriba. Laminar Pharma aims to develop next-generation medicines, nutraceutical and cosmetic products based on the … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 33 | |
X-Bolt Orthopedics "Simplicity, the ultimate sophistication" (Leonardo da Vinci) X-Bolt brings simplicity and efficiency to trauma surgery, whilst improving quality of life for patients. surgery, orthopedics, medical devices, distribution, hip trauma, sales, marketing, and design Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 13 | |
Minervax ApS Developing a maternal vaccine for Group B Streptococcus MinervaX is pursuing the development of a maternal vaccine for the prevention of adverse pregnancy outcomes and life-threating infections caused by Group B streptococcus (GBS). The vaccine is based on adjuvanted proteins antigens covering close to 100% of clinical GBS isolates. Group B Streptococcal (GBS) is the leading cause of life-threatening infections in newborns. Colonization of pregnant women with GBS may lead to adverse pregnancy outcomes such as late abortions, stillbirths, and preterm delivery. Colonization may also lead to life-threatening infections in newborns for the first 3 months of life, causing pneumonia, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 57 | |
HeartBeat.bio AG REINVENTING CARDIAC DRUG DISCOVERY HeartBeat.bio (HBB) is an emerging TechBio company developing a next-generation drug discovery platform for heart diseases. Our so-called Cardioid Drug Discovery Platform is based on a proprietary iPSC-derived single and multi-chamber cardiac organoid model. We combine this unique human biology with state-of-the-art hardware solutions to industrialize the organoid cultivation and screening process as well as AI-supported software for high-content and big data analysis. HBB pursues an end-to-end human-centric drug discovery approach along the entire pre-clinical value chain: Starting with target identification and validation, disease modeling, hit identification and confirmation, leading up to compound development and profiling … Type: Startup Activities: deeptech Technologies: SaaS Synthetic Biology | 0 | 0 | 0 | 22 | |
ulrich medical dedicated to you. ulrich medical develops, produces and markets innovative medical technology. Founded in 1912, this year we celebrate our 112th anniversary. Physicians and users worldwide trust in our many years of experience. With product divisions in spinal implants and contrast media injectors for CT and MRI, we offer a comprehensive portfolio of innovative products. We are one of the few in the industry with development and production in Germany and we rely on the most modern manufacturing technology. Our products stand worldwide for the highest degree of quality "Made in Germany". We employ more than 600 employees internationally. And … Type: SMB Activities: manufacturing martech Technologies: Synthetic Biology | 1 | 0 | 1 | 324 | |
Eurofins Advinus Preferred Partner for Discovery and Development Services Eurofins Advinus Private Limited is a premier contract research, development and manufacturing organization (CRDMO) serving diverse industries to help advance their R&D programs within defined timelines with highest level of quality. With 30+ years of GLP experience, we have a proven track record of successfully delivering many integrated and stand-alone projects to meet our partner’s requirements. We offer a complete suite of drug discovery and development services. Our drug discovery services include medicinal and synthetic chemistry, ADMET/DMPK and Discovery Biology across various therapeutic areas. Our preclinical development services include process development, DMPK and … Type: Large company Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 1 | 892 | |
CareDx, Inc. Dedicated to transplant patients. Leading with innovation. CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 682 | |
bioWORLD Molecular Tools and Laboratory Essentials Since its founding in 1992, bioWORLD has established, maintained, and succeeded in its core mission to manufacture and supply high-quality molecular tools, biological reagents, and laboratory supplies to analytical laboratories, academia institutions, and research corporations globally. bioWORLD specializes in numerous product lines for the Life Sciences and Biotechnology industries. With product focuses including bioAffinity reagents for protein purification and proteomics research, recombinant proteins and synthetic peptides, plant, microbiological, animal, and yeast media, and many other fields. In addition, bioWORLD offers services including custom peptide synthesis and antibody production. The company's headquarters are in Dublin, Ohio, … Type: SMB Activities: manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 38 | |
Arterra Bioscience S.p.A. We care about everybody's health Arterra Bioscience is a biotech company listed on the “Euronext Growth Milan” market of Borsa Italiana since 2019, founded in Naples by M. Gabriella Colucci in 2004 with the aim of developing technologies and innovative solutions that find application in various industrial sectors. Arterra is a company strongly linked to the Campania region from which it derives the natural raw materials underlying many of its actives, as well as being able to take advantage of the ideas and enthusiasm of its young researchers. Biotechnology, R&D, Cosmetics, medical Device, Agriculture, and Agrifood Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 40 | |
Proteus by Seqens Biocatalysis from Lab to Industrial Scale Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes. Proteus offers: - An exclusive and diversified microorganism collection (including micro-algae and thousands of bacteria and archaebacteria extremophiles strains) - 1,000 sequenced strains, combined with data mining tools, offering a unique pool of millions enzymes - Patented directed evolution technologies (EvoSightTM & L-ShufflingTM) to optimize enzymes performances - A multidisciplinary skilled team dedicated to custom bioprocess development for client’s applications - Seqens CDMO capabilities enabling large scale biocatalytic production of chemicals & pharmaceuticals … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 24 | |
Nextep Health Cabinet de conseil en stratégie spécialisé dans les problématiques de santé Nextep, a catalyst for ideas and expertise : "When all healthcare players want to create more value for patients " Founded in 1999, Nextep is an independent healthcare consultancy firm specialized in 6 complementary practices: Strategy & Performance; Business Development; Public Affairs & Strategic communication; Market Access & Health Economics; Training; Publishing Specialized in strategic health issues. Our interventions for customers throughout Europe and the United States are intended to support managers – from innovative SMEs to multinationals – in their development, both in medicine, biotech, the “medical device” … Type: SMB Activities: consulting healthtech govtech Technologies: Synthetic Biology | 19 | 3 | 16 | 49 | |
Wavepaths Music technology responsive to who you are and how you feel. Designed for therapeutic work. linktr.ee/wavepaths Wavepaths unifies immersive arts, psychotherapies and intelligent technologies into a new approach to well-being. Music, Art, Intelligent Technologies, Psychedelic Medicine, and Therapeutic Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 12 | |
AgGene Developing technology for tomorrow's crops AgGene is an agriculture biotechnology company focused on the development of plant traits to address major challenges faced during crop production. Our flagship technology addresses the demand for improving protein content in plant tissues using advanced genomics and molecular plant breeding techniques including gene-editing. AgGene is also focused on collaborative relationships with other agriculture companies and independent plant breeders to help develop plant biotech traits to address issues including climate resilience. biotechnology, gene editing, agriculture, molecular genetics, molecular biology, genomics, genetic engineering, and plant biology Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology | 2 | 2 | 0 | 4 | |
Hesperos Inc. The Human-on-a-Chip Company Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 2 | 62 | |
DermTech, LLC DermTech, LLC provides genomic analysis of skin samples collected non-invasively using its Smart Stickers. DermTech develops and markets products to facilitate the assessment of melanoma. Melanoma, Gene Expression Testing, Pigmented Lesions, Dermatology, and Dermatopathology Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 104 | |
Animal-Free Safety Assessment Collaboration The AFSA Collaboration works to accelerate the adoption of modern, human-relevant approaches to testing. The Animal-Free Safety Assessment (AFSA) Collaboration is a unique multi-sector partnership between non-profit, corporate, and philanthropic leaders working to advance acceptance and use of animal-free safety science as a gold standard across regulatory frameworks worldwide. AFSA brings together corporate, philanthropic and non-profit leaders who share the goal of accelerating a modern, species-relevant approach to safety assessment globally to better protect people and our planet, and hasten the replacement of animal testing. Our members cooperate on a range of educational and policy topics specific to the cosmetics, … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 9 | 1 | 9 | 1 | |
Synthesea Building a biological platform to produce low-cost, sustainable omega-3 for aquaculture. Powered by Synthetic Biology. Powered by Synthetic Biology, Synthesea is developing synthesis technology that is transferable to a wide range of lipids (AKA fats). And we're starting with omega-3. Omega-3 oil is a necessity for fish to grow nutritiously and is naturally found in algae, which wild fish eat. Fish grown in aquaculture (farms for fish livestock) cannot eat algae due to scaling limitations. Therefore, the current solution is to feed wild-caught fishmeal (crushed fish) to aquaculture fish. This rapidly depletes wild fish stocks and is continuously increasing the … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
AQUA Cultured Foods Indulge your seafood cravings, without the catch. 🎣 Eat your heart out. AQUA makes seafood safe again. Fins down, AQUA is earth’s most exciting fermentation-enabled fiber. While AQUA seafood looks like fish, tastes like fish, and feels like fish––it's 100% fish-free. We hyper-control the growing environment so every morsel of tuna, scallop, squid, and shellfish is flawless––and forever available to feed billions of seafoodies. alternative meat, alternative seafood, alternative protein, food tech, biotech, fermentation, and sustainability Type: Startup Activities: foodtech Technologies: Synthetic Biology | 4 | 2 | 3 | 19 | |
Elite Sweets Elite Sweets is on a mission to redefine sweets. We make delicious protein packed donuts that are low sugar and keto 🍩 Elite Sweets is makers of The Elite Donut- A protein packed, low sugar donut, that is keto friendly, gluten free, soy free and absolutely delicious. Consumer Packaged Goods Type: Startup Activities: foodtech Technologies: Synthetic Biology | 2 | 1 | 1 | 22 | |
Nextbiotics Nextbiotics, engineering viruses for good. Biotech, CRISPR, and Digital Biology Type: Startup Activities: it services Technologies: Synthetic Biology | 1 | 1 | 0 | 3 | |
Next Big Innovation Labs® Next Big Innovation Labs® is a Deep Tech Lifesciences platform, developing 3D Bioprinting Technology and Products Next Big Innovations Labs (NBIL) is a startup of enthusiastic individuals on a mission to confront the world’s most challenging problems in the healthcare space. We are a research driven startup working on a novel approach to tackle the current muddle vexing the pharmaceutical, clinical and cosmetic R&D sectors. We feel we can crack these problems only by using the disruptive technology of 3D Bioprinting. At NBIL, we focus to solve the organ availability crisis plaguing the entire globe using 3D Bioprinting; aiming to … Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology | 4 | 1 | 3 | 30 | |
Agomab Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 49 | |
Kappa Santé [Automatic translation follows] CRO specializing in real-life data Kappa Santé was born from the desire to provide quality services in the fields of epidemiology, pharmacoepidemiology and interventions in public and digital health. The company was founded at the end of 2002 and is based in Paris Kappa Santé is an independent CRO, member of ENCEPP (European Network of Centers for Pharmacoepidemiology and Pharmacovigilance), AFCRO (French Association of CROs), Oséo Excellence (community of entrepreneurs chosen by Oséo) and the Cap digital competitiveness cluster. We have now participated in over 100 studies in many therapeutic areas Public Health, Pharmacoepidemiology, Medical Devices, Intervention … Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 9 | 4 | 2 | 41 | |
RB3D [Automatic translation follows] We support your efforts at work to reduce the arduousness and risks of MSDs We propose to reduce the risks of MSDs in industry, agriculture and logistics. Our manipulators and exoskeletons are adapted to handling applications, in a large number of industrial sectors. Our cobots and exoskeletons aim to bring you power and endurance to increase your efficiency and carry out your arduous manual tasks without the risks of MSDs. Collaborative robots, Exoskeletons, Improvement of working conditions, ergonomics, anti MSDs, risk prevention, cobots, job analysis, industry, logistics, public works, Viticulture, automobile, and market gardening Type: SMB Activities: it services Technologies: Synthetic Biology | 13 | 7 | 9 | 11 | |
Prestwick Chemical Libraries We design and offer a range of smart chemical libraries to ensure a high hit rate Prestwick Chemical is a French provider of smart libraries. For almost 20 years, the company, founded by Prof. Camille-Georges Wermuth, has provided medicinal chemistry services and screening libraries to accelerate small molecules drug discovery. Prestwick has a large portfolio of smart Libraries designed to ensure maximal chemical diversity, possibly to access new IP while remaining within reach of both low and high throughput screening processes. They are constantly updated and improved. Our clients have reported high quality hit generation rate. The Prestwick Chemical Library®, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 7 | |
efFORMip [Automatic translation follows] www.efformip.com • www.twitter.com/ASS_EFFORMIP efFORMip is an association that works to integrate physical activity into the patient's care pathway. Under the acronym, Equipe pour encourager la FORMe dans l'intérêt du patient, it was created in 2005 under the leadership of Professor Danièle Rivière and Dr. Frédéric Depiesse, where several doctors and sports professionals in Midi-Pyrénées joined forces, convinced of the interest of practicing physical activity in a therapeutic approach. Since 2018, it has been chaired by Dr. Bernard Bros and managed by a board of directors whose members come from both the medical and physical activity fields. Its … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 3 | 0 | 3 | 10 | |
Invacare France [Automatic translation follows] Yes, you can. Invacare® is the leading provider of Home Care Medical Devices. Our Products and Services are recognized for their quality and innovative nature. By listening to the needs of our Customers, we contribute to giving them back independence and autonomy in their daily lives. wheelchair, electric wheelchair, home care, medical bed, senior scooter, oxygen therapy, kuschall, alber, positioning, mobility, aquatec, and rea Type: SMB Activities: transporttech deeptech healthtech consumer services Technologies: Synthetic Biology | 2 | 0 | 1 | 140 | |
Ademtech [Automatic translation follows] Our innovative technology from French research (CNRS Bordeaux) makes it possible to manufacture monodisperse polymer beads (CV<20%), highly magnetic (iron oxide content >70%), calibrated from 100 to 500 nm (+/- 10 nm), offering a high specific surface area (5 to 25 m2/g). These magnetic beads are stable, sensitive and quickly separable under a magnetic field. These particles are particularly well suited to be integrated into microfluidic devices. Their surface is, and can be, functionalized by the grafting of molecules of biological interest, in order to capture, isolate and separate, analyze or purify biological entities (molecules, oligonucleotides, cells, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 28 | |
Polyplus now part of Sartorius We power your science Polyplus, now part of Sartorius is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. Headquartered in Europe, the Polyplus team continues to grow globally with operations in the United States … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 3 | 1 | 117 | |
ATLANTIC BONE SCREEN Your partner for preclinical research in Oncology, Inflammation, musculoskeletal disorders and osteoarticular diseases Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services in the field of bone and joint diseases and more particularly in bone diseases from tumor origin. Thanks to its high expertise, Atlantic Bone Screen also evaluates biomaterials, either for orthopedic or dental applications. We provide high-quality services to support the characterization of drug candidates, nutraceuticals, biomaterials,... Located in Nantes, North-West of France and created in 2005 by Ronan LE BOT, CEO of the company, Atlantic Bone Screen puts … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 4 | 24 | |
Veterans Village of San Diego Leave No One Behind Veterans Village of San Diego (VVSD) has served all veterans since 1981 and is dedicated to “Leave No One Behind.” With five locations throughout San Diego County, VVSD is the only program of its kind in the United States and is nationally recognized as the leader in serving homeless military veterans. Each year VVSD provides services to more than 3,000 military veterans throughout the County of San Diego. Clinical Treatment, Housing, Employment, Mental Health, Mental Health Care, Homelessness, Fighting Homelessness, Healthcare, Volunteer Work, Volunteers, Counseling, Rehab, Rehabilitation, Job Placement, Job Skills, Life Skills, Veterans, Helping Veterans, … Type: SMB Activities: military edtech Technologies: Synthetic Biology | 6 | 0 | 6 | 140 | |
Mibelle Biochemistry Inspired by nature - realized by science 🍏 Inspired by nature – Realized by science Designing ideas for added value In the fast-moving cosmetic industry, innovation is the most important factor as it enables us to deliver new claims, new efficacy tests, new applications, new biochemical findings, as well as new marketing and communication tools to effectively differentiate products. At Mibelle Biochemistry, our mission is to design the most innovative actives for our customers. Inspired by nature – realized by science Our scientists transform naturally derived plant compounds into truly functional bioactive cosmetic ingredients. Our R&D team makes use of … Type: SMB Activities: cosmetics deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 81 | |
Oxford Drug Design A drug-discovery company focused on oncology. Follow us on Twitter @OxDrugDes Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes. Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology A.I. - Machine Learning A.I. | 4 | 1 | 2 | 10 | |
Synairgen plc We are a specialist respiratory biotech company focused on severe viral lung infections Synairgen is a specialist respiratory biotech company whose primary focus is developing its investigative inhaled IFN-β candidate for the treatment of severe viral lung infections as potentially the first host-targeted broad-spectrum antiviral treatment delivered directly into the lungs. Founded by University of Southampton (UK) Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic in 2003, Synairgen is quoted on AIM (LSE: SNG). For more information, please visit www.synairgen.com. Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 4 | 1 | 1 | 29 | |
Source BioScience Industry-leading provider of Genomic and Histopathology services, including Cellular & Digital Pathology. Source BioScience, comprised of Source LDPath and Source Genomics, provides industry-leading laboratory services in Genomics and Histopathology, partnering with biotechnology, pharmaceutical, healthcare and academia. Source LDPath provides an end-to-end clinical diagnostic service, from histopathology, including digital pathology and AI, through to molecular diagnostic services. Source LDPath already supports over 85 NHS Trusts and a comprehensive network of Private Healthcare clinics to expand their diagnostic capabilities, ensuring diagnostic results are delivered within clinically actionable timeframes. Source LDPath brings pioneering expertise in digital pathology and AI implementation, helping NHS pathology … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 0 | 5 | 193 | |
MedicAlert Foundation - United States Saving lives since 1956. Original creator of the medical ID and 24/7 emergency response service. 501(c)(3) nonprofit. Established in 1956, the nonprofit MedicAlert Foundation pioneered the use of medical IDs and delivers the most dependable, responsive, and trusted Emergency Identification and Medical Information Network. MedicAlert provides the functionality of an e-health information exchange through an innovative combination of a unique patient identifier linked to a personal health record and a live 24/7 U.S.-based emergency response service. MedicAlert Foundation medical IDs alert emergency personnel to a member’s primary health conditions, medications or implanted medical devices. In addition to its 24-hour emergency … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 80 | |
Laboratoires Vivacy Laboratories VIVACY is a French manufacturer specialising in the design, production and distribution of high quality injectable medical devices for use in the field of Anti-ageing, especially in Medical Aesthetics and Viscosupplementation. Founded in 2007 by specialists qualified in biopolymers and injectable product technologies with more than 25 years’ experience in the field, the company has acquired recognised expertise in dermal fillers based on hyaluronic acid and natural antioxidants, mannitol and sorbitol. The company has also created new technologies for use in ophthalmology (I.SPACE®), rheumatology (KARTILAGE®), gynecology (DESIRIAL®) and is currently developing in other medical viscosupplementation fields. Thanks to its … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 278 | |
Fedmind [Automatic translation follows] Nourish your mind. *Closed company* Fedmind is a health application for therapeutic education of overweight or obese patients. A player in the field of prevention and medical research, Fedmind works to offer a different, complementary and comprehensive treatment of the disease. The application offers a complete one-year program with online therapy to work on the causes of obesity, education on balanced nutrition and physical activity circuits adapted to overweight people. With the help of a caring community through weekly support groups, monitoring by the care team via the application and FedAlert', a tool to disarm eating crises … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 4 | 1 | 1 | 2 | |
BioPharmGuy Worldwide Biotech Company Database BioPharmGuy is a website that functions as a directory of companies in the biotechnology, pharmaceutical, medical device & life science industries. We offer services for businesses as well as job seekers. The site is constantly being updated to ensure we have the most accurate and high quality, free-to-use database. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Rapid Release Therapy Innovator of targeted, high speed vibration technology for professionals focused on musculoskeletal health & wellness. Rapid Release Technology is a commercial grade vibration therapy used by professional athletes and practitioners for fast pain relief. Unlike percussive devices (massage guns), vibration therapy may be used on areas percussive therapy cannot treat, such as the cranial, spinal column, TMJ, bony prominences and tendons. Our latest innovation, the Rapid Release PRO3 is the new flagship device. It has been engineered and refined to make it lighter, smoother, quieter, and best of all, cordless with a long battery life. health & wellness, chiropractors, physical … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 13 | |
Amparo Revolutionizing Prosthetics Amparo is redesigning prosthetic care to enhance the experience for amputees & orthopaedic technicians. With over 4500 patients fitted in 5 continents, Amparo products are present in over 200 clinics worldwide. We believe that prostheses for recent amputees can be improved to help people with a faster physical and psychological recovery. Prosthetics, Medical Engineering, Amputees, Social Entrepreneurship, Innovation, Design Thinking, Medtech, Assistive Devices, Worldwide, O&P, and Health Type: Startup Activities: deeptech healthtech Technologies: New Materials Synthetic Biology | 6 | 1 | 5 | 9 | |
UTI-lizer Revolutionizes the Urinary Tract Infection diagnostics! Urinary tract infections (UTIs) are the most common bacterial infections in women. More than half of all women suffer at least once from a UTI. Current over-the-counter tests are not sensitive enough, and diagnosis of UTI is today based on symptoms only, leading to non-optimal treatment and unnecessary use of antibiotics. We have miniaturized culture-based bacterial detection (gold standard for UTI diagnosis) in a dipstick format with a highly sensitive and quantitative digital bioassay. We can detect and quantify bacteria in the clinically relevant range, without any complicated lab instruments, and with a readout … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
Nextkidney Dialysis Anytime, Anywhere. NextKidney’s mission is to develop and commercialize the Neokidney home hemodialysis device. Placing the patient and his quality of life at the center of its approach, the company uses innovative technologies to offer a safe, practical and easy-to-use solution as quickly and widely as possible throughout the world. medical device, Manufacturing , Dialysis, and Home Dialysis Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 47 | |
Ousia Pharma Danish biotech company developing peptide-small molecule drugs for treatment of obesity Ousia Pharma is a biotech spin-out from the University of Copenhagen developing novel peptide-drug conjugates for treatment of obesity and metabolic diseases. The company uses a proprietary targeting approach in which peptides are used to deliver modulators of synaptic plasticity to drive a potent and sustained weight loss without compromising safety. A main objective of Ousia Pharma is to advance the development of the lead weight loss drug candidate (OP-56) within general obesity. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
Circio Holding ASA Developing novel circular RNA and immunotherapy medicines. Circio Holding ASA is a clinical stage company developing immune activators to target difficult-to-treat diseases. The company’s mission is to deploy vector-based technology to create a novel class of targeted, multi-functional circRNA medicines. It has established a cutting-edge circular RNA (circRNA) program and is collaborating with Prof Michael Uhlin and a team at the Karolinska Institutet in Stockholm with the intent to develop next generation RNA therapeutics for various applications. The company also has a mutant RAS cancer vaccine program, with two collaborative clinical trials underway in the USA and Norway. It is … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 20 | |
iPC H2020 Giving clinicians the tools and knowledge to create individualized treatment plans for their paediatric cancer patients. Cancer in children is rare but when it happens, clinician prescribed treatment options are not always as clear as one would hope. In fact, on average, only a quarter of oncology patients respond to the drug therapy they receive. There are many reasons for this but evidence shows that a personalized treatment plan or treatment that is based on the patient's fundamental biology could significantly enhance treatment outcomes. As it turns out, the personalized treatment plan can be as complex as the cancer itself … Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 3 | 0 | |
Nimbus Therapeutics Applying deep computational chemistry expertise to create novel small molecule therapeutics. At Nimbus, we design breakthrough medicines. Utilizing our powerful structure-based drug discovery engine, we create potent and selective small molecule compounds targeting proteins that are known to be fundamental drivers of pathology in highly prevalent human diseases and which have proven difficult for other drug makers to tackle. With a decade-plus track record of success, we’ve built a world-class team in both computationally driven drug discovery and early clinical development while continuing to move the needle for patients. computational chemistry, biochemistry, small molecule therapeutics, oncology, immunology, metabolism, and drug … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 1 | 6 | 104 | |
ApconiX Nonclinical safety experts asking the right questions at the right time to make safer, more effective drugs ApconiX was formed by three AstraZeneca colleagues with the drive and ambition to create a world-renowned company known for its expertise in nonclinical safety toxicology and ion channel electrophysiology. The company is founded on the skills and experience of a growing team with a wide range of expertise in preclinical drug safety. The model for the pharmaceutical industry has evolved in recent years with large pharma reducing internal capability and outsourcing key skills to trusted partners. There are many more SMEs who also … Type: Startup Activities: biotech Technologies: Synthetic Biology | 7 | 0 | 7 | 57 | |
Sense4Care We design, develop and produce wearables and medical devices based on the identification of human movement patterns Sense4Care is a company specialized in the design and manufacture of medical devices, which aims to improve the quality of life of people. Based in Barcelona area, is formed by a high qualified team that come from the fields of engineering, medicine and business. The company develops and markets cutting-edge solutions based on the knowledge generated by the Universitat Politècnica de Catalunya (UPC) in research projects mainly related to fall detection and Parkinson’s disease, among others. ehealth, technology, medical, parkinson, and fall detection Type: Startup Activities: silvertech deeptech healthtech manufacturing Technologies: Synthetic Biology | 5 | 0 | 0 | 10 | |
EKPO Fuel Cell Technologies GmbH The future mobility – already in series production today. EKPO Fuel Cell Technologies is a leading joint venture in the field of development and large-scale production of fuel cell stacks for CO2-neutral mobility. We are a full-service supplier for fuel cell stacks and components used in trucks, buses, light commercial vehicles, but also SUVs and larger passenger cars and for rail and marine applications. We build on the industrialization expertise of the two established international automotive suppliers ElringKlinger and Plastic Omnium. Type: Startup Activities: energytech transporttech Technologies: Synthetic Biology | 2 | 1 | 2 | 136 | |
TSC Connected Care Turnkey Digital Health Solutions TURNKEY SOLUTIONS TSC Connected Care provides turnkey solutions to help free up beds and staff to deliver more and better patient care! Sensium, our ICU grade wireless monitoring technology, has been shown to reduce Length of Stay by 10-30%. Thelma, our smart medication dispenser, can free up to 66% of home care workforces. Vital signs monitoring, Wireless medical devices, and Ultra-low power wireless technologies Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 2 | 35 | |
RoslinCT Your Advanced Cell & Gene Therapy CDMO Partner RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the groundbreaking technology cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has harnessed cutting-edge science to advance the development of human medicines. With a remarkable heritage in the field, the company has achieved significant milestones, including being among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR-edited stem cell-based therapy for a major disease to … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 3 | 0 | 3 | 339 | |
Krystal Biotech, Inc. A commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines for high unmet medical needs. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 2 | 261 | |
Microsynbiotix, Ltd. A Sundew company We are creating a potentially revolutionary algal platform technology. Thanks to major advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. The cost of the synthetic biology tools has dropped. We are building our technology based on solid, peer-reviewed science[1][2][3][4]. By using microalgae as an oral delivery vehicle, we can substantially cut the labor and post-processing production costs, allowing us to produce effective vaccines that are much more affordable and user-friendly. Our technology can reduce or eliminate the use of antibiotics, reduce fish mortality rates … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 1 | 2 | 36 | |
Mursla Bio Pushing the boundaries of biopsy technology Mursla Bio is a pioneering biotech company on a mission to transform cancer care by pushing the boundaries of biopsy technology. Its breakthrough dynamic biopsy platform combines the strengths of both tissue and liquid biopsies without their limitations in invasiness or biological insights. Dynamic biopsy is made possible by coupling the latest of extracellular vesicle (EV) and extracellular omics science with Mursla Bio’s pioneering EV technologies. Mursla Bio’s initial focus is to transform the surveillance of liver cancer in high-risk populations - the fastest growing cause of cancer related deaths. Mursla Bio is currently … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 | 1 | 15 | |
Inspire Medical Systems We are committed to elevating and redefining the standard of care for Obstructive Sleep Apnea. Inspire Medical Systems, Inc. has developed the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient’s unique breathing patterns. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition. Obstructive Sleep Apnea, ENT, sleep, patient engagement, digital health, medical device, medical devices, Sleep Apnea, Healthcare, … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 0 | 2 | 1,169 | |
OrthoHeal Healing Comfortably ! OrthoHeal is the leading Medical Technology (Med-Tech) company that specializes in the orthopedic medical devices. We relentlessly strive to intensively research and innovate technologies by discovering newer horizons of potential solutions for improving patient-care and state-of-the-healthcare. We specifically emphasize on improving the experience for post-operative orthopedic recoveries while also discovering, inventing and enhancing the potentials for comfort and convenience in healthcare. Leveraging our knowledge and technology OrthoHeal has flourished as a company with several innovative products with disruptive technologies under the brand-name FlexiOH®. FlexiOH® is the next generation orthopedic immobilization technology invented, developed, patented and delivered world-wide … Type: Startup Activities: healthtech deeptech martech Technologies: New Materials Synthetic Biology | 1 | 0 | 0 | 58 | |
CITO Medical New Product Development of Medical Devices & Biotech Instruments CITO Medical is an engineering firm specializing in new product development of medical devices, life science lab equipment, point of care diagnostic instruments and microfluidic cartridges. CITO partners with technology startups, Fortune 500 companies and academic institutions to bring product and research ideas to life through precision engineering, innovative hardware and solution-driven design and development. A unique blend of engineering principles and modern design techniques enable our engineers to turn your ideas into working products and solutions that transform everyday life around the world. Core capabilities include: Mechanical Engineering, Electrical Engineering, … Type: Startup Activities: healthtech deeptech biotech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 15 | |
AbiliLife Join us on our mission to reduce back injuries and create a safer workforce with the Calibrace+ back brace. AbiliLife is a leading medical technology company transforming how people manage their mobility and balance challenges. Our innovative products are designed to enhance the quality of life and empower individuals to live independently and pain-free. Our flagship product, the Calibrace+, is a unique back brace that provides targeted support to the trunk and helps improve posture and balance. The Calibrace+ is a game-changer for workforces. Back injuries and pain are common problems in many industries, reducing productivity, absenteeism, and healthcare costs. … Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
Médecins Sans Frontières/Doctors Without Borders (MSF) UK and Ireland MSF UK and Ireland. Médecins Sans Frontières/Doctors Without Borders is an international medical humanitarian aid organisation. We save peoples' lives in conflict zones, epidemics and natural disasters. Independence, neutrality and impartiality are at the core of everything we do. Our network of medics, logistical professionals and administrative staff spans more than 70 countries. Our medical teams carry out more than nine million patient consultations a year. Our activities run from vaccination campaigns to complex surgery in war zones. From building hospitals to recruiting local teams, our non-medical staff make sure our field projects run smoothly, no matter what happens. And … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 13 | 3 | 6 | 193 | |
Crown Bioscience We support drug discovery through translational research across oncology and immuno-oncology. Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) providing discovery, preclinical, and translational platforms to advance oncology and immuno-oncology. Known for their high quality and expansive in vivo, in vitro and ex vivo preclinical models, they partner with their clients to quantify the efficacy and pharmacological profile of their drug candidate before they move into the clinic. The company is the only preclinical CRO to provide tumor organoid services utilizing HUB technology and has the world’s largest commercially available PDX collection. Additionally, further … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 2 | 571 | |
IMM- le dispositif médical innovant [Automatic translation follows] Act, Innovate, Support, Moderate costs For 30 years, IMM has been working alongside healthcare professionals and offering them medical devices that meet the highest standards of requirement. In a context of an aging population with constantly increasing healthcare costs and a growing demand for home care, our common goal is to allow patients to receive their treatment in the best conditions of safety and comfort. Being close to all healthcare stakeholders, understanding the challenges of care allows us to reference and constantly evolve our devices to allow everyone to benefit from the latest technological advances and respond … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 2 | 1 | 1 | 14 | |
DIVA Expertise [Automatic translation follows] DEEP INNOVATION on adipose tissue. Research partner from the cell to Humans D.I.V.A. Expertise is a consulting, strategy and development company in scientific research in the fields of Health, Nutrition, Cosmetics and Aesthetics. Its objectives are to support manufacturers in the structuring, organization and development of their research in order to optimize its costs, deadlines and results. Personalized support from our experts boosts the R&D process of a product by promoting Creativity, Innovation and Collaboration. Its core expertise is targeted on the biology of fatty tissue called adipose, recognized as an endocrine organ with a fundamental and … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 7 | 1 | 4 | 9 | |
Nanobiotix Leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes. Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is one rooted in designing pioneer physical based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. Nanobiotix’s novel first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Furthermore, Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies. … Type: SMB Activities: nanotech biotech deeptech Technologies: Synthetic Biology | 15 | 7 | 10 | 141 | |
i-MEDS Healthcare i-MEDS Healthcare - Innovative Medication Delivery Solutions. i-DoneaTM from i-MEDS Healthcare is the e-Health solution that makes taking medication at home easier and safer. i-DoneaTM is an extension of drug delivery circuit from the pharmacy to home. i-DoneaTM is an intelligent medication dispenser, connected 24/24 and designed to accurately and unfailingly administer the vital medications people require every day. i-DoneaTM, a unique &amp; innovative product: - Simple &amp; user-friendly design - Large touch-sensitive user interface- Innovative use for an extension of the drug delivery circuit at home- Technical innovation- 3-pronged approach: Therapeutic Education / Simplification / Automation, i-DoneaTM de i-MEDS … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 11 | 4 | 8 | 6 | |
Early Drug Development Group (E2DG) Boost your program in Oncology We offer professional support all along the drug development life cycle, from lead optimization to Phase I clinical trials in oncology. We optimize and accelerate your R&D programs, based on our drug positioning-oriented philosophy. Early Drug Development Group is focused on building partnerships and strategic alliances with academic research institutions, universities, governmental agencies, small size biotechnology partners and investment funds. COLLABORATION WITH US IMPROVES YOUR RESOURCES INVESTMENT AND STRENGTHENS YOUR EARLY DRUG DEVELOPMENT PROGRAM IN ONCOLOGY. YOUR KEY BENEFITS • Assistance on preclinical, pharmacological and CMC approaches, clinical studies design, regulatory strategies and trials implementation … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
Eurofins | Dermscan Pharmascan Assesses your product's future Eurofins Cosmetics & Personal Care is an aligned network of first-class laboratories across Europe, North America, Asia, Oceania and Africa, using the latest technologies and providing an unrivaled range of clinical, sensory, chemical, in vitro and microbiological testing services. Established in 1990 and in continuous expansion ever since, Dermscan joins Eurofins in 2018 in line with Eurofins Cosmetics’ strategy to expand its leading global cosmetic testing footprint. ISO 9001: 2015 certified, Eurofins Dermscan assess the safety, tolerance and efficacy of raw materials, finished products, food supplements, medical devices, etc. Thanks to facilities in France, Poland, Tunisia, … Type: SMB Activities: biotech cosmetics deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 148 | |
Cogentis Therapeutics, Inc. Developing first in class therapies for the treatment of dementia. Cogentis Therapeutics is an early stage biotechnology company with a mission to develop and commercialize an innovative disease-modifying therapeutic for dementias such as frontotemporal dementia (FTD) and Alzheimer’s disease (AD) to improve patients’ quality of life and reduce the burden of disease on their families, providers, and the overall healthcare system. Our immediate goal is to develop a peptide-based compound, CT-526, for FTD. neurodegeneration, neuropeptide, frontotemporal dementia, Alzheimer's disease, and progressive supranuclear palsy Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 7 | |
Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR TTM) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers. oncology, cancer, biotechnology, immunotherapy, CAR T, and autoimmune Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 3 | 3 | 281 | |
SOMAVAC® Medical Solutions, Inc. Pioneering SOMAVAC® Deep Tissue Negative Pressure Therapy. SOMAVAC® Medical Solutions, Inc. is a MedTech company developing and pioneering new technology platforms to mitigate surgical complications, improve treatment protocols, and reduce the overall cost of healthcare. Our platforms are led by our patented SOMAVAC® Deep Tissue Negative Pressure Therapy which is the first powered negative pressure therapy device cleared for seroma prophylaxis. For patients undergoing breast reconstruction and/or mastectomies, negative pressure delivered by SOMAVAC® removes fluid as it is produced, obliterates dead space, and holds tissues together which have been shown to prevent seromas. Seromas can lead to surgical complications like … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
IBT-Bioservices Accelerating research & development Integrated BioTherapeutics LLC (IBT Bioservices) is a contract research organization (CRO) offering in vitro and in vivo services as well as products to support your biomedical research and development needs. Whether you are a biotech startup or an established pharmaceutical company, IBT serves as your trusted partner, simplifying the development process and accelerating your journey toward bringing innovative biotherapeutics to patients in need. The team of highly skilled scientists, researchers, and industry experts at IBT work collaboratively to deliver exceptional results and accelerate the development process for its clients. By offering comprehensive services and concierge-level support … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 2 | 11 | |
Neopharm Boston CRO with extensive expertise in small molecule chromatography and purification We are Neopharm Boston Inc., formerly Averica Discovery Services, a Contract Research Organization (CRO) recognized by our proficiency in small molecule analysis and purification. Our enduring legacy of excellence positions us as a strategic partner within the pharmaceutical industry. Our recent expansion has equipped us to deliver a comprehensive, fully integrated array of services, facilitating a seamless journey from development and preclinical stage to commercial launch. At Neopharm Boston, our remarkable high throughput capabilities extend beyond advanced instrumentation to encompass a highly skilled and capable team. This synergy enables us … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 3 | 1 | 2 | 6 | |
OneSkin Science-based solutions designed to maximize your healthspan. OneSkin is a longevity company on a mission to transform the way we think about skin and aging. Founded by a team of four female PhDs, OneSkin’s products focus on skin longevity. OneSkin’s proprietary peptide, OS-01, is the first ingredient designed to reduce skin's biological age by improving skin barrier, supporting DNA damage repair, and preventing the accumulation of aged cells. Data-driven Science , Human 3D Skin Models, and Genomics Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 40 | |
Quevos Quevos are high protein, low carb chips made from egg whites. Finally a delicious snack you can feel great about eating! The original egg white chips! Quevos are high protein, low carb chips made from egg whites. Finally, a delicious snack you can feel great about eating! Type: Startup Activities: foodtech Technologies: Synthetic Biology | 3 | 1 | 1 | 4 | |
Rebion Rebion provides a “Window to the Brain” to identify functional impairment of between the brain/eye pathway. Based on years of research and trials at major medical institutions, Rebion is commercializing the breakthrough Neural Performance Scanning (NPS) to identify and help manage life-altering diseases that manifest from functional impairments in the brain. NPS portable point-of-care devices provide previously unavailable information for fast and impactful triage, making early disease detection, intervention and customized treatment more accessible. Medical Devices, Optics, Vision Screening, Amblyopia, and Strabismus Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 16 | |
Enable Injections, Inc. Enable's body-worn enFuse® drug delivery technology delivers large volumes (5 - 25mL) via subcutaneous administration. Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience. Enable's body-worn enFuse® delivers large-volume therapeutics via subcutaneous administration, with the aim of improving convenience, potentially supporting improved safety outcomes, and advancing healthcare system economics. For more information, please visit www.enableinjections.com. *Approved in the United States in combination with a specific drug, more information: https://enableinjections.com/our-products. combination product, patient-centric technology, subcutaneous drug delivery, high-viscosity, wearable drug delivery device, large volume drug delivery device, enFuse, on-body … Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 5 | 1 | 4 | 188 | |
Mymee Mymee identifies unique dietary and environmental factors that can worsen autoimmune disease & COVID long haul symptoms. Mymee is the first personalized trial & care platform that helps patients gain control of unpredictable flares associated with autoimmune disease and long COVID. Autoimmune Disease, N of 1, Chronic Disease, Precision Medicine, Digital therapeutics, Population Health, Digital Care, Digital Health, Autoimmunity, Personalized Trials, Women's Health, and Long COVID Type: Startup Activities: healthtech Technologies: Synthetic Biology | 3 | 2 | 2 | 14 | |
Likarda Improving the Efficacy of Cellular Therapies Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Our revolutionary method to coat cells with stealth hydrogels, called Core Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body. Unlike our competitors, Likarda has developed a library of over 50 different hydrogel formulations that work with Core Shell Spherification®, resulting in the ability to uniquely tailor the coating molecules to the specific requirements of the therapeutic cells themselves. From durable and long-term coatings to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 0 | 1 | 15 | |
VRG Therapeutics Regional leader in preclinical R&D with a world-class protein evolution tech platform for CGT applications Our mission is to cure diseases via targets and MoAs that cannot be reached with traditional approaches. Leveraging our unique platform, we optimize peptides/proteins of natural origin using directed evolution to create cutting-edge CGT products or peptide-based pharmaceuticals. VRGT’s management and staff members were selected based on their international research experience and outstanding pharma industry achievements. Our people have outstanding professional expertise in preclinical/clinical R&D and scientific project management, pharmacology, business development and medical marketing. For years, they have worked in the most prestigious academic … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 26 | |
Epizyme On August 12, 2022, Epizyme was acquired by Ipsen, expanding Ipsen’s oncology portfolio. Epizyme now operates as an Ipsen company with a shared goal of delivering innovative treatment options to underserved patients. Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 1 | 3 | 99 | |
Optinose We are a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. Our first commercial product, XHANCE® (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing our proprietary Exhalation Delivery SystemTM (EDS®) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). In September 2017, the U.S. Food and Drug Administration (FDA) approved XHANCE for the treatment of nasal polyps in patients 18 years of age or … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 146 | |
Venatorx Pharmaceuticals, Inc. Discovering & developing novel anti-infectives to treat multi-drug resistant bacterial & hard-to-treat viral infections. Venatorx Pharmaceuticals is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. antibiotics, antiinfectives, antivirals, drug development, drug discovery, pharmaceuticals, #battlesuperbugs, #WorkingToFightAMR, clinical, research, #squashsuperbugs, biotech, and antimicrobialresistance Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 76 | |
Quanterix Discovery Fueled by Ultra-Sensitivity Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 16 | 0 | 13 | 447 |